Algeron
Algeron Uses, Dosage, Side Effects, Food Interaction and all others data.
Algeron is under investigation in clinical trial NCT01889433 (An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C).
| Trade Name | Algeron |
| Generic | Cepeginterferon alfa-2B |
| Cepeginterferon alfa-2B Other Names | Algeron, Cepeginterferon Alfa 2 B, Cepeginterferon alfa-2B, Pegylated human interferon A-2B |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Algeron
